Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Overview of attention for article published in The Lancet, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 56 news outlets
blogs: 2 blogs
policy: 1 policy source
twitter: 85 X users

patent: 1 patent
facebook: 5 Facebook pages
wikipedia: 1 Wikipedia page
f1000: 1 research highlight platform

Citations

dimensions_citation: 335 Dimensions

Readers on

mendeley: 349 Mendeley

Summary News Blogs Policy documents X Patents Facebook Wikipedia Research highlights Dimensions citations

So far, Altmetric has seen 1 review on a research highlight platform.

Recommended in Faculty Opinions

26 Mar 2018

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.